SNPHF
Price:
$10.99
Market Cap:
$602.84B
Santen Pharmaceutical Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and commercialization of pharmaceuticals and medical devices. Headquartered in Osaka, Japan, its core focus lies in ophthalmology. The company boasts a robust pipeline of treatments for various eye conditions. For glaucoma and ocular hypertension, its offerings include DE-111 and DE-130A, both in Phase III clinical trials; DE-117, available in Japan; DE-126, currently in Phase IIb development; and DE-128, which is marketed in Europe and undergoing Phase II/III trials in the United States. Santen also addresses other ophthalmic conditions: DE-114A for allergic conjunctivitis, DE-07...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2010-06-09
Stock Exchange
OTC
Ticker
SNPHF
According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 13.15%. This represents a change of 303.47% compared to the average of 3.26% of the last 4 quarters.
The mean historical ROE of Santen Pharmaceutical Co., Ltd. over the last ten years is 7.96%. The current 13.15% ROE has changed 65.28% with respect to the historical average. Over the past ten years (40 quarters), SNPHF's ROE was at its highest in in the March 2026 quarter at 5.23%. The ROE was at its lowest in in the September 2022 quarter at -9.26%.
Average
7.96%
Median
8.61%
Minimum
-5.08%
Maximum
12.67%
Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 168.67%
Maximum Annual ROE = 12.67%
Minimum Annual Increase = -271.21%
Minimum Annual ROE = -5.08%
| Year | ROE | Change |
|---|---|---|
| 2026 | 12.58% | -0.66% |
| 2025 | 12.67% | 45.50% |
| 2024 | 8.71% | -271.21% |
| 2023 | -5.08% | -163.05% |
| 2022 | 8.06% | 168.67% |
| 2021 | 3.00% | -61.51% |
| 2020 | 7.80% | -29.01% |
| 2019 | 10.98% | -10.92% |
| 2018 | 12.33% | 44.86% |
| 2017 | 8.51% | -58.53% |
The current ROE of Santen Pharmaceutical Co., Ltd. (SNPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.32%
5-year avg
7.39%
10-year avg
7.96%
Santen Pharmaceutical Co., Ltd.’s ROE is less than Livzon Pharmaceutical Group Inc. (13.95%), less than Sumitomo Pharma Co., Ltd. (41.78%), less than Sumitomo Pharma Co., Ltd. (41.78%), less than Bumrungrad Hospital Public Company Limited (25.10%), less than Camurus AB (publ) (16.39%), less than Siegfried Holding AG (15.68%), less than Welcia Holdings Co., Ltd. (6.34%), less than Carl Zeiss Meditec AG (6.69%), less than Carl Zeiss Meditec AG (6.69%), less than Ono Pharmaceutical Co., Ltd. (8.54%),
| Company | ROE | Market cap |
|---|---|---|
| 13.95% | $6.06B | |
| 41.78% | $4.22B | |
| 41.78% | $4.15B | |
| 25.10% | $4.33B | |
| 16.39% | $3.21B | |
| 15.68% | $3.69B | |
| 6.34% | $3.42B | |
| 6.69% | $2.49B | |
| 6.69% | $2.61B | |
| 8.54% | $6.53B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Santen Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Santen Pharmaceutical Co., Ltd. (SNPHF)?
What is the highest ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?
What is the 3-year average ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?
What is the 5-year average ROE for Santen Pharmaceutical Co., Ltd. (SNPHF)?
How does the current ROE for Santen Pharmaceutical Co., Ltd. (SNPHF) compare to its historical average?